Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Insulet to Establish Highly-Automated Manufacturing Operation in the United States
BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation  (NASDAQ:PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ®  Insulin Management System (Omnipod System), today announced plans to establish an automated manufacturing operation in the United
View HTML
Toggle Summary Insulet Announces Executive Appointments
Dr. Trang Ly , Prominent Artificial Pancreas Researcher, Appointed Vice President and Medical Director Brittany Bradrick Appointed Vice President, Strategy and Corporate Development BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation  ( NASDAQ : PODD) (Insulet or the Company), the leader in
View HTML
Toggle Summary Insulet Reports Second Quarter 2016 Financial Results
Second Quarter Revenue of $87.3 Million , up 44% Year-Over-Year, Exceeds Expectations Company Raises Mid-Point of Full Year 2016 Revenue Guidance by $10 Million Gross Margin Improves to 57.8% BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation ( NASDAQ : PODD) ( Insulet or the Company), the
View HTML
Toggle Summary Insulet Corporation to Present at Upcoming Investor Conferences
BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation ( NASDAQ : PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at three upcoming investor conferences in New York City ,
View HTML
Toggle Summary Insulet Launches New Educational iPad App: Toby's T1D Tale
Omnipod ® Mascot Provides Diabetes Education to Children and Caregivers through Stories, Tips and Trivia BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation  ( NASDAQ : PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ®  Insulin Management System
View HTML
Toggle Summary Insulet Corporation to Announce Second Quarter 2016 Financial Results on August 3, 2016
BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation ( NASDAQ : PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the second quarter of 2016 on August 3, 2016
View HTML
Toggle Summary New Data Demonstrate Benefits of Insulet's Omnipod® System for People with Type 1 and Type 2 Diabetes
Two Publications in the Journal of Diabetes Science and Technology BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation  ( NASDAQ : PODD), the leader in tubeless insulin pump technology with its Omnipod Insulin Management System (Omnipod System), today announced two online publications of new
View HTML
Toggle Summary Insulet Partners with Joslin Diabetes Center to Implement a Unique Training Certification for Insulet's Clinical Team
Insulet's Clinical Team Receives Certification in Advanced Diabetes Educator in Pump Therapy (ADEPT™) Program BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation  ( NASDAQ : PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ®  Insulin Management
View HTML
Toggle Summary Insulet to Present Omnipod® Clinical Studies on Type 1 and Type 2 Diabetes During the American Diabetes Association's 76th Scientific Sessions
Company Presentations Include Compelling Clinical Data Demonstrating the Efficacy of the Omnipod System on Glycemic Control in Patients with Type 1 and Type 2 Diabetes Dr. Frank Doyle to Share Exciting New Data on the Insulet-Licensed Artificial Pancreas Algorithm Company Exhibiting at Booth 1301;
View HTML
Toggle Summary Insulet Launches New Omnipod® Podder™ Community Platform
New Platform Provides Enhanced Support, Information, and Social Engagement for Growing Community of Podders BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation  ( NASDAQ : PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ®  Insulin Management
View HTML
Toggle Summary Insulet Reaffirms Second Quarter and Full Year 2016 Guidance
BILLERICA, Mass. , May 3, 2016 /PRNewswire/ --  Insulet Corporation ( NASDAQ : PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its OmniPod ® Insulin Management System (OmniPod System), today reaffirmed its second quarter and full year 2016 guidance.
View HTML
Toggle Summary Insulet Reports First Quarter 2016 Financial Results
First Quarter Revenue of $81.2 Million, up 69% Year-Over-Year, Exceeds Expectations
View HTML
Toggle Summary Insulet Corporation to Announce First Quarter 2016 Financial Results on April 28, 2016
BILLERICA, Mass. , March 30, 2016 /PRNewswire/ --  Insulet Corporation ( NASDAQ : PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its OmniPod ® Insulin Management System, today announced plans to release its financial results for the first quarter of 2016 on
View HTML
Toggle Summary Insulet Names Aiman Abdel-Malek, Ph.D. Senior Vice President of Advanced Technology and Engineering
Experienced Senior Executive with Proven Record Leading Global R&D Teams
View HTML
Toggle Summary Insulet Announces Organizational Enhancements
Shacey Petrovic Promoted to President, Insulet Diabetes ProductsCharles Alpuche Appointed Senior Vice President of Global Manufacturing and Operations
View HTML